Cargando…
The Long Non-coding Road to Atherosclerosis
PURPOSE OF REVIEW: To summarize recent insights into long non-coding RNAs (lncRNAs) involved in atherosclerosis. Because atherosclerosis is the main underlying pathology of cardiovascular diseases (CVD), the world’s deadliest disease, finding novel therapeutic strategies is of high interest. RECENT...
Autores principales: | Josefs, Tatjana, Boon, Reinier A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415749/ https://www.ncbi.nlm.nih.gov/pubmed/32772181 http://dx.doi.org/10.1007/s11883-020-00872-6 |
Ejemplares similares
-
Nucleic Acid–Based Therapies for Atherosclerosis
por: Mäkinen, Petri, et al.
Publicado: (2020) -
MicroRNAs as Biomarkers for Myocardial Infarction
por: Salic, Kanita, et al.
Publicado: (2012) -
Sortilin as a Regulator of Lipoprotein Metabolism
por: Strong, Alanna, et al.
Publicado: (2012) -
Genetics of Triglycerides and the Risk of Atherosclerosis
por: Dron, Jacqueline S., et al.
Publicado: (2017) -
Novel RNAi-Based Therapies for Atherosclerosis
por: Ruotsalainen, Anna-Kaisa, et al.
Publicado: (2021)